MeCP2 (Methyl CpG-binding protein 2) is widely studied in neuronal systems[1] since it acquired biomedical importance with the discovery that mutations in its gene, located at Xq28 in human, determined a profound neurodevelopmental autism spectrum disorder, the Rett syndrome (RTT)[2]. This evidence concerns the gene MECP2 and autism spectrum disorder.